Heska Corporation Acquires Biotech Laboratories U.S.A. LLC to Enter Rapid Assay Veterinary Diagnostics Market
September 1, 2021
Heska Corporation acquired majority ownership of Biotech Laboratories U.S.A. LLC, a Rockville, Maryland developer of rapid point-of-care lateral flow diagnostics for animals. The acquisition (closed Sept. 1, 2021) brings Biotech's rapid assay pipeline, manufacturing expertise and IP into Heska's product portfolio as the company moves to launch a full line of single-use rapid assays for veterinarians and livestock producers.
- Buyers
- Heska Corporation
- Targets
- Biotech Laboratories U.S.A. LLC
- Sellers
- Biotech Holdings U.S.A. LLC
- Industry
- Medical Devices
- Location
- Maryland, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Heska Corporation Acquires Lacuna Diagnostics
January 13, 2021
Healthcare Services
Heska Corporation announced an agreement to acquire 100% of Lacuna Diagnostics, a Fort Collins–based developer of point-of-care digital cytology and telemedicine pathology services for the veterinary market. The acquisition gives Heska immediate specialty clinical services capabilities — including a digital telemedicine cytology platform and an expert network of pathologists — and is intended to expand Heska's product and revenue streams to better serve veterinary customers.
-
Mars, Incorporated Acquires Heska Corporation
April 3, 2023
Medical Devices
Mars, Incorporated agreed to acquire Heska Corporation for $120.00 per share (approximately $1.3 billion equity value), bringing the veterinary diagnostics company into Mars Petcare's Science & Diagnostics business. The acquisition is intended to broaden Mars' point-of-care diagnostic offerings, accelerate R&D and innovation, and expand access to veterinary diagnostics for companion animal health globally.
-
Ott Scientific Acquires American Bionostica
April 1, 2021
Medical Devices
Ott Scientific has acquired American Bionostica, Inc., a developer and manufacturer of specialty lateral flow assays; the acquisition was effective April 1 and ABI will operate inside Ott Scientific’s Ethos Biosciences subsidiary. The American Bionostica team will join Ott Scientific, with expanded research and production capacity planned at Ott Scientific’s new ISO13485/cGMP space in Logan Township, New Jersey.
-
US BioTek Laboratories Acquires RealTime Laboratories
March 19, 2024
Healthcare Services
US BioTek Laboratories, a Pike Street Capital portfolio company, has acquired Dallas-based RealTime Laboratories to expand its diagnostic testing capabilities, specifically mycotoxin and infectious disease testing. The deal broadens the combined organization’s services and geographic footprint while both labs continue operating at their respective locations.
-
Discovery Life Sciences Acquires QualTek Molecular Laboratories
May 5, 2019
Healthcare Services
Discovery Life Sciences (based in Huntsville, Alabama) has acquired QualTek Molecular Laboratories, a provider of CAP/CLIA-accredited and GLP-capable immunohistochemistry (IHC) laboratories in California and Pennsylvania. The acquisition expands Discovery's histopathology and IHC assay development capabilities and integrates QualTek's services with Discovery's biospecimen, sequencing, flow cytometry and multiomic annotation offerings to accelerate biomarker validation and drug/diagnostic development.
-
R-Biopharm AG Acquires AusDiagnostics
June 7, 2022
Biotechnology
German biotechnology company R-Biopharm AG has acquired Australian molecular diagnostics manufacturer AusDiagnostics. The purchase adds AusDiagnostics' multiplex MT-PCR platforms, extraction reagents and laboratory automation capabilities to R-Biopharm's clinical diagnostics portfolio, supporting capability expansion and internationalization into new clinical, veterinary and applied testing markets.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.